Dealmakers newsletter: April 2008
Welcome to April's edition of the Dealmakers newsletter from CurrentPartnering.
Sponsored by: Intralinks | Verticali | EuroPLX | DMS Data Systems
If not already signed up to receive our newsletters, do so here.
In this issue:
- Editor's corner
- New partnering reports
- In the news - April 2008
- New best practice articles
- Forthcoming events
- Scorecards - newly updated with latest deals
- People on the move
- Partnering resources: Glossary of terms
The April issue of Dealmakers is sponsored by:
EuroPLX 36
Historically, this partnering event delivers an average of more than 23 pre-scheduled appointments per participating company for Collaborative Agreements in Prescription Drugs from Clinical Candidates to Value Added Generics - Development, Licensing, Marketing and Distribution.
In addition, attending companies are expected to offer or look for R&D services, supporting technologies, contract manufacture, and the supply of APIs and intermediates.
For more information, please log on to http://www.europlx.com
EDITOR'S CORNER
Dealmaking has been relatively slow so far in 2008. However, there is increasing activity as both bigpharma and biotechs start to announce some interesting collaborations.
Hot off the press is the news that Novartis is to buy a stake in Nestle's Alcon Laboratories for $39billion.
Also of interest is Takeda's global alliance with Cell genesys for development and commercialization of GVAX immunotherapy for prostate cancer.
Our new report Distribution Agreements in Biopharma provides comprehensive understanding and unprecedented access to the distribution agreements entered into by the worlds leading biopharma companies.
The report complements our other recent reports: Merger and Acquisitions Agreements in Biopharma and Co-promotion and Co-marketing Agreements in Biopharma.
You can also view the leading deals so far this year in our updated Scorecards.
Until next time - happy dealmaking!
- Steve Poile
NEW PARTNERING REPORTS
Distribution Agreements in Biopharma
The Distribution Agreements in Biopharma report provides comprehensive understanding and unprecedented access to the distribution partnering agreements entered into by the worlds leading biopharma companies Distribution Agreements in Biopharma
Bigpharma Partnering Agreements
The Bigpharma Partnering Agreements report provides comprehensive and unprecedented access to the partnering agreements entered into by the worlds leading fifty biopharma companies Bigpharma Partnering Agreements
Merger and Acquisition Agreements in Biopharma
The Merger and Acquisition Agreements in Biopharma report provides comprehensive understanding and unprecedented access to the merger and acquisition (M&A) agreements entered into by the worlds leading biopharma companies Merger and Acquisition Agreements in Biopharma
Co-promotion & Co-marketing Agreements in Biopharma
The Co-promotion and Co-marketing Agreements in Biopharma report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading biopharma companies Co-promotion & Co-marketing Agreements in Biopharma
Also:
Practical Guide to Finding Partners in Biopharma
CurrentPartnering’s Practical Guide to Finding Partners in Biopharma provides a comprehensive overview of all the steps required to identify and secure partnering either for an in-licensing or out-licensing activity Practical Guide to Finding Partners in Biopharma
IN THE NEWS
The latest partnering developments - March And April 2008:
- Novartis to buy a stake in Nestle's Alcon Laboratories for $39billion
- Cell Genesys and Takeda global alliance for development and commercialization of GVAX immunotherapy for prostate cancer
- Acusphere licenses hydrophobic drug delivery system to Cephalon
- Teva to Acquire Bentley Pharmaceuticals
- MethylGene in worldwide research and license agreement With Otsuka
- Shire and TAP to co-promote LIALDA
- Daiichi Sankyo extends alliance with MorphoSys for use of HuCAL GOLD to develop novel antibody therapies
- genOway in master service agreement with Boehringer Ingelheim
NEW BEST PRACTICE ARTICLES
There is no substitute for face time
How often have you received an interesting business opportunity offer from a person or company totally unknown to you, and how often did you think that it would be easier to assess the offer if you would know the person? There is no substitute for face time
Research Collaborations: Avoiding Possible Traps
Research collaborations offer institutions the opportunity to achieve goals they might not accomplish on their own: breakthrough discoveries with manageable costs Research Collaborations: Avoiding Possible Traps
FORTHCOMING EVENTS
Here is our suggested partnering events for summer 2008.
Impact China IV
Beijing, China, May 4-6, 2008
As the pre-eminent event on the Chinese pharmaceutical market, Impact China IV provides you with the most vital and progressive sessions lead by the foremost experts in the industry Impact China IV
Euro-Biotech Forum 2008
Hotel Arts Barcelona, Barcelona, Spain - May 5-7, 2008
The industry's most exclusive 1:1 partnering meeting for American and European life science companies Euro-Biotech Forum 2008
Healthcare Investor & Corporate Development Conference 2008
Chicago, Il, USA - May 13-14, 2008
SRI’s annual event is highly regarded in the industry and well attended by healthcare CEOs, CFOs, business development officers and the financial & investment community including commercial & investment banking, private equity, LBO, venture funds, institutional investors, M&A specialists and senior, mezzanine and other lenders Healthcare Investor & Corporate Development Conference 2008
13th Annual Pharma and Biotech Licensing and Deal Making Summit
New Brunswick, NJ, USA - May 15-16, 2008
Discover new partners, financing and investment options for growth 13th Annual Pharma and Biotech Licensing and Deal Making Summit
BioPharm America 2008
Buckland, Atlanta, USA - September 9-10, 2008
BioPharm America is where biotech industry partnerships get started. Based on the same winning formula used in EBD Group’s distinguished European partnering conferences BIO-Europe and BIO-Europe Spring, BioPharm America is expected to become the premier stand-alone bio-pharma partnering event in North America BioPharm America 2008
SCORECARDS
Our scorecards are updated with the latest deals to break into our most valuable deal rankings - the latest deal for 2008 to enter our partnering top 20 is Kyowa Hakko and Amgen's $520m deal is for Kyowa Hakko's humanized monoclonal antibody KW-0761 worldwide.
- Partnering Top 20 - 2008
- Partnering Top 20 - 2007
- Partnering since 2000
- M&A Top 20 - 2008
- M&A Top 20 - 2007
- M&A since 2000
- Bigpharma Top 25 partnering - 2007
PEOPLE ON THE MOVE
The following people have been reported on the move during the weeks of March 2008:
Teresa Winslow, James Miskel, Luc Clouâtre, Richard Katz, Hampton Corley, Michael Rochelle, to name just a few
read more about the latest people on the move
If you have news about a business development executive who is on the move - let us know
PARTNERING RESOURCES: GLOSSARY
A comprehensive glossary of partnering terms, together with example clauses - Glosssary
Do you have specific glossary terms that you would like to see in our website? Give us your ideas here
CurrentPartnering is an online provider of best practice, business information and intelligence for dealmakers
Advertizing and sponsorship
CurrentPartnering offers several advertising options, enabling your product or service to be promoted to our global business development audience - further details available online.
or contact us to discuss your requirements.
Steve Poile, Editor
Web: http://www.CurrentPartnering.com
Mail: Current Partnering, Allanmere House, 6 Hobgate, York, YO24 4HF, United Kingdom
Tel: +44 7896 656732
Fax: +44 8703 305993
Deal term reports
The information you provide is excellent and we look forward to doing more business with you in the future
...You have published very timely and interesting materials.... I am excited.... It is an excellent publication and pretty well up to date...
CurrentPartnering Reports
The latest reports on best practise for dealmakers available from CurrentPartnering
Quick links
Term of the week...
Heads of agreement A pre-agreed document that outlines the key elements and structure of the planned deal.